VAR2CSA DBL1-2 : A Lead Antigen for Malaria Vaccine Development

Jungle fever caused by Plasmodium constitutes a noteworthy medical issue is as yet a standout amongst the most widely recognized dangerous irresistible maladies on the planet. In 2016, the worldwide count of jungle fever achieved 216 million cases and 445,000 passing, a substantially larger part of them coming about because of Plasmodium falciparum infection.1 Individuals living in high P. falciparum transmission settings step by step obtain insusceptibility to the most serious clinical signs of the contamination. Every year, PM is in charge of 20% of stillbirths in sub-Saharan Africa, 11% of every infant passing in sub-Saharan Africa, and 10,000 maternal passing all around.


Over 50 million women are exposed to the risk of malaria during pregnancy every year. Malaria during pregnancy is a leading global cause of maternal morbidity and adverse pregnancy outcomes. Adhesion of infected erythrocytes to placental chondroitin-4-sulfate (CSA) has been linked to the outcome of placental malaria. Accumulated evidence strongly supports VAR2CSA as the leading placental malaria vaccine candidate.

Recombinant proteins encompassing the VAR2CSA high-affinity CSA binding site have been generated, and their activity as immunogens that elicit functional (inhibitory) and cross-reactive antibodies against CSA-binding parasites assessed. 



The expression of His-tagged proteins was compared in four different expression systems and their capacity to bind specifically to CSA was analyzed. CHO cells and E. coli Shuffle cells were the two expression systems able to express some of the recombinant proteins in reasonable amounts. Larger analytical scale production of DBL1x-2× (3D7) and DBL3x-4ε (FCR3) best expressed in CHO and E. coli Shuffle cells were performed. 


Purified proteins were administered to rats either alone or adjuvant with human approved adjuvants. Analysis of the functionality and cross-reactivity of the induced antibodies allowed us to down-select the DBL1x-2(3D7) expressed in E. coli Shuffle cells as the best antigen to be transitioned to further clinical development in order to protect future pregnant women living in malaria-endemic areas against the severe clinical outcomes of placental malaria.

To know more visit our webpage




Comments

  1. Jessica Morgan23 June 2020 at 17:43

    Good news this is to everyone out there with different health challenges, as I know there are still a lot of people suffering from different health issues and are therefore looking for solutions. I bring you Good news. There is a man called Dr ehiaguna a herbal practitioner who helped cure me from HSV (2), i had suffered from this diseases for the past 5 years and i have spent so much money trying to survive from it. I got my healing by taking the herbal medicine Dr ehiaguna sent to me to drink for about 14 days . 3 days after completion of the dosage, I went for a medical checkup and I was tested free from HSV. all thanks to God for leading me to Dr ehiaguna who was able to cure me completely from this deadly diseases, I’m sharing this so that other people can know of this great healer called Dr ehiaguna because I got to know him through elizabeth who he cured from HIV. I was made to understand that he can cure several other deadly diseases and infections. Don’t die in ignorance or silent and don’t let that illness take your life. Contact Dr ehiaguna through his email drehiaguna@gmail.com You can also whatsapp/call him on:+2348073908953 .He cure all forms of disease {1}HIV/AIDS {2}DIABETES {3}EPILEPSY {4} BLOOD CANCER {5} HPV {6} BRAIN TUMOR {7} HEPATITIS {8}COPD{9} SICKLE AND ANAEMIA.etc Be kind enough to share as you received.  

    ReplyDelete

Post a Comment

Popular posts from this blog

HIV Free New World is Coming in 2020

Image
HIV look into has progressed significantly since the illness was found in the 1980's. Antiretroviral treatment was a noteworthy point of reference that has changed the lives of millions, yet the objective currently is to discover an HIV fix before 2020. HIV can as of now be overseen successfully insofar as patients adjust to an administration of customary antiretrovirals ( ARVs ). The treatment implies that individuals with HIV can carry on with a typical span of life inasmuch as they take everyday drugs, despite the fact that in the event that they quit doing as such the viral level quickly increments and begins indeed assaulting their safe framework.  Nonetheless, another bit of research proposes this may not generally be the situation. Truth be told, the antibody -based treatment at present being trialed among 13 HIV-dynamic members brought about five patients having the capacity to keep a hold a low, non-perilous viral load — in spite of one of them not havi...
Read more

Vaccines for Adolescents: A new generation of vaccines

Image
Teenagers, similar to grown-ups, were prescribed to get lockjaw supporters at regular intervals; most requiring their first promoter portion around age 11. Other than this, nonetheless, most youths did not require extra vaccines except if they missed one in adolescence. By 2005, vaccines explicitly prescribed for teenagers were suggested for sub-bunches dependent on where they lived or restorative conditions that they had. In any case, another gathering of immunizations ended up accessible in the last piece of the decade. Vaccines for meningococcus and human papillomavirus (HPV) and in addition extended suggestions for flu and pertussis presently give chances to young people to be secured as they enter their high school years. 2000 Recommended Vaccines Td Catch-up MMR Hepatitis B Varicella Sub-groups Hepatitis A 2005 Recommended Vaccines Td Catch-up MMR Hepatitis B Varicella Sub-groups Hepatitis A Pneumococcus Influenza 2010 Recommended Vaccines Tdap HPV Men...
Read more